- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 1, 2026 | 7.79M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 7.79M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 7.75M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $27.44K |
| Capex | Q1 2026 · Mar 31, 2025 | $0 |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $2.13M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $2.25M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $9.51M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $18.04M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $12.42M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $13M |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | $12.96M |
| Stockholders Equity restated | Q1 2026 · Dec 31, 2024 | $13.96M |
| Stockholders Equity | Q1 2026 · Jan 1, 2024 | $10.33M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $137.44M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $135.68M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $149.86M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $148.68M |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.04 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$0.17 |
| Net Income | Q1 2026 · Mar 31, 2026 | −$331.43K |
| Net Income restated | Q1 2026 · Mar 31, 2025 | −$1.35M |
| Revenue | Q1 2026 · Mar 31, 2026 | $5.89M |
| Revenue | Q1 2026 · Mar 31, 2025 | $5.18M |